25-hydroxyprotopanaxadiol has been researched along with protopanaxadiol, (3beta,12beta)-isomer in 1 studies
Studies (25-hydroxyprotopanaxadiol) | Trials (25-hydroxyprotopanaxadiol) | Recent Studies (post-2010) (25-hydroxyprotopanaxadiol) | Studies (protopanaxadiol, (3beta,12beta)-isomer) | Trials (protopanaxadiol, (3beta,12beta)-isomer) | Recent Studies (post-2010) (protopanaxadiol, (3beta,12beta)-isomer) |
---|---|---|---|---|---|
21 | 0 | 19 | 14 | 0 | 11 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, N; Piao, HR; Wu, CF; Zhang, H; Zhao, JM; Zhao, YQ | 1 |
1 other study(ies) available for 25-hydroxyprotopanaxadiol and protopanaxadiol, (3beta,12beta)-isomer
Article | Year |
---|---|
Novel dammarane-type sapogenins from Panax ginseng berry and their biological activities.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Dammaranes; Drug Screening Assays, Antitumor; Humans; Panax; Plant Roots; Sapogenins; Structure-Activity Relationship; Triterpenes | 2011 |